CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
Both will develop cancer vaccine candidates in selected haematological and solid tumour indications
Read More
Tag: cancer vaccines
Lilly signs up to cancer vaccines with CureVac deal
Eli Lilly has signed up CureVac to develop cancer vaccines based on its mRNA technology, in a deal that could potentially be worth more than $2.6 billion to the German biotech.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
